Completed NA INTERVENTIONAL 3-arm NCT00370916

Reducing Transition Drug Risk

Reducing Transition Drug Risks After Patient Transfer

Sponsor: Icahn School of Medicine at Mount Sinai

Interventions Pharmacist-initiated medication reconciliation Physician-initiated medication reconciliation

Updated 7 times since 2017 Last updated: Apr 6, 2015 Started: Oct 31, 2005 Primary completion: Mar 31, 2006 Completion: Sep 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00370916, this NA trial focuses on Hospitalization and remains completed. Sponsored by Icahn School of Medicine at Mount Sinai, it has been updated 7 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Aug 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Aug 2018 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Oct 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Icahn School of Medicine at Mount Sinai
US Department of Veterans Affairs
University of Victoria

Data source: VA Office of Research and Development

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• The Bronx, United States